Cargando…

MicroRNA-mediated drug resistance in breast cancer

Chemoresistance is one of the major hurdles to overcome for the successful treatment of breast cancer. At present, there are several mechanisms proposed to explain drug resistance to chemotherapeutic agents, including decreased intracellular drug concentrations, mediated by drug transporters and met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutanzi, Kristy R., Yurchenko, Olga V., Beland, Frederick A., Checkhun, Vasyl’ F., Pogribny, Igor P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156306/ https://www.ncbi.nlm.nih.gov/pubmed/21949547 http://dx.doi.org/10.1007/s13148-011-0040-8

Ejemplares similares

MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
por: Kindrat, Iryna, et al.
Publicado: (2015)

MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis
por: de Conti, Aline, et al.
Publicado: (2017)

Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach
por: Starlard-Davenport, Athena, et al.
Publicado: (2013)

MicroRNA-in drug resistance
por: Li, Haoran, et al.
Publicado: (2014)

Gene Expression and DNA Methylation Alterations During Non-alcoholic Steatohepatitis-Associated Liver Carcinogenesis
por: Dreval, Kostiantyn, et al.
Publicado: (2019)

MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
por: Zhong, Shanliang, et al.
Publicado: (2016)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Dai, Yue-chu, et al.
Publicado: (2021)

Regulation of ABCB1 activity by microRNA-200c and microRNA-203a in breast cancer cells: the quest for microRNAs’ involvement in cancer drug resistance
por: Armada, Ana, et al.
Publicado: (2019)

Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice
por: Tryndyak, Volodymyr P., et al.
Publicado: (2016)

The Role of Exosomal microRNA in Cancer Drug Resistance
por: Guo, Qiao-ru, et al.
Publicado: (2020)

Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations
por: Kutanzi, Kristy R., et al.
Publicado: (2016)

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
por: Pogribny, Igor P
Publicado: (2010)

Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in Human Liver Cells and Association with Hepatocellular Carcinoma
por: Yu, Dianke, et al.
Publicado: (2015)

MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36
por: Xia, Wenfei, et al.
Publicado: (2020)

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
por: Cosentino, Giulia, et al.
Publicado: (2021)

From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment
por: PIVA, ROBERTA, et al.
Publicado: ( 201)

MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer
por: Jung, Eunsun, et al.
Publicado: (2021)

Cerebellar Oxidative DNA Damage and Altered DNA Methylation in the BTBR T+tf/J Mouse Model of Autism and Similarities with Human Post Mortem Cerebellum
por: Shpyleva, Svitlana, et al.
Publicado: (2014)

Passive Microwave Radiometry and microRNA Detection for Breast Cancer Diagnostics
por: Fisher, Leonid, et al.
Publicado: (2022)

MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 [Retraction]
Publicado: (2022)

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
por: Rastgoo, Nasrin, et al.
Publicado: (2017)

microRNA-mediated regulation of microRNA machinery controls cell fate decisions
por: Liu, Qiuying, et al.
Publicado: (2021)

Fractionated low-dose exposure to ionizing radiation leads to DNA damage, epigenetic dysregulation, and behavioral impairment
por: Koturbash, Igor, et al.
Publicado: (2017)

An asymmetric bulge enhances artificial microRNA‐mediated virus resistance
por: Zhang, Hui, et al.
Publicado: (2019)

MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone
por: Kara, Sonat Pınar, et al.
Publicado: (2021)

MicroRNA in Teleost Fish
por: Bizuayehu, Teshome Tilahun, et al.
Publicado: (2014)

ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer
por: Roberts, Justin T., et al.
Publicado: (2018)

Circulating microRNA, secreted microRNA and exogenous plant microRNA
por: Zhang, Chenyu
Publicado: (2012)

Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers
por: Yan, Max, et al.
Publicado: (2015)

Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3
por: Ao, Xiang, et al.
Publicado: (2016)

Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer
por: Chen, Yuling, et al.
Publicado: (2022)

Cotranslational microRNA mediated messenger RNA destabilization
por: Tat, Trinh To, et al.
Publicado: (2016)

Discovering the first microRNA-targeted drug
por: Lindow, Morten, et al.
Publicado: (2012)

MicroRNA Regulation of Breast Cancer Stemness
por: Humphries, Brock, et al.
Publicado: (2021)

Human microRNA similarity in breast cancer
por: Jing, Ying, et al.
Publicado: (2021)

An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells
por: Yamamoto, Yusuke, et al.
Publicado: (2011)

MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2
por: Gao, Xitao, et al.
Publicado: (2019)

Multi-Drug Resistance against Second-Line Medication and MicroRNA Plasma Level in Metastatic Breast Cancer Patients
por: Dehghani, Mehdi, et al.
Publicado: (2023)

microRNA-1301-mediated inhibition of tumorigenesis
por: FANG, LIN, et al.
Publicado: (2011)

Epigenetic and microRNA-mediated regulation in diabetes
por: Muhonen, Pirkko, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bnl8fabobil07okuleugdqo30d